Integra LifeSciences Holdings Corp. is planning a public offering of 5,250,000 common shares.
The Plainsboro, N.J.-based surgical implant maker intends to grant the underwriters a 30-day option to buy an additional 787,500 common shares.
Integra plans to use net proceeds to buy additional shares, to cut outstanding revolving borrowings under its senior credit facility.
J.P. Morgan and Wells Fargo Securities will be joint book-running managers for the offering.
